Emerging Macrolide Resistance in Mycoplasma pneumoniae in Children Detection and Characterization of Resistant Isolates

被引:90
作者
Li, Xiao [1 ]
Atkinson, T. Prescott [2 ]
Hagood, James [2 ]
Makris, Chris [2 ]
Duffy, Lynn B. [1 ]
Waites, Ken B. [1 ]
机构
[1] Univ Alabama, Dept Pathol, Birmingham, AL 35249 USA
[2] Univ Alabama, Dept Pediat, Birmingham, AL 35249 USA
关键词
Mycoplasma pneumoniae; respiratory infection; polymerase chain reaction; macrolide resistance; children; REAL-TIME PCR; COMMUNITY-ACQUIRED PNEUMONIA; MOLECULAR ANALYSIS; STRAINS; FRANCE; GENE;
D O I
10.1097/INF.0b013e31819e3f7a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Epidemiologic data from Asia have documented the rapid and extensive emergence of macrolide resistance in Mycoplasma pneumoniae. This drug resistance has also been documented in Europe and recently in the United States, but there is very little information currently available on its prevalence. A rapid technique to identify macrolide-resistant M. pneumoniae is needed to guide management of patients with community-acquired respiratory infections. Methods: Culture and Minimum Inhibitory Concentration testing identified macrolide-resistant M. pneumoniae infection in 2 seriously ill hospitalized children with community-acquired pneumonia. A portion of the 23S ribosomal RNA gene from 2 macrolide-resistant M. pneumoniae isolates from these children as well as 4 laboratory-induced macrolide-resistant strains was amplified by PCR, and the PCR products were sequenced to identify mutations associated with macrolide resistance. A real-time PCR assay was designed to identify 3 known mutations in the 23S rRNA gene associated with macrolide resistance and applied to the clinical specimens from which these isolates were obtained and to the bacterial isolates. Results: Macrolide-resistant M. pneumoniae from both children were found to carry an A2063G transition in the 23S rRNA gene previously identified in resistant isolates from China, Japan, France, and recently in an encephalitis outbreak in Rhode Island. Three laboratory-induced mutant strains had an A2064G mutation whereas the other one had an A2063G mutation. A real-time PCR assay successfully detected the macrolide-resistant M. pneumoniae directly in clinical specimens and discriminated them from wild-type isolates. Conclusions: Macrolide-resistant M pneumoniae can be associated with prolonged severe respiratory infection in children. Real-time PCR offers a rapid method of diagnosing macrolide resistance in community-acquired respiratory infections due to M. pneumoniae.
引用
收藏
页码:693 / 696
页数:4
相关论文
共 14 条
[1]   Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae:: Serological results of a prospective, population-based study in primary health care [J].
Korppi, M ;
Heiskanen-Kosma, T ;
Kleemola, M .
RESPIROLOGY, 2004, 9 (01) :109-114
[2]   Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, during five successive winter periods [J].
Layani-Milon, MP ;
Gras, I ;
Valette, M ;
Luciani, J ;
Stagnara, J ;
Aymard, M ;
Lina, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1721-1726
[3]   Antimicrobial Susceptibility of Mycoplasma pneumoniae Isolates and Molecular Analysis of Macrolide-Resistant Strains from Shanghai, China [J].
Liu, Yang ;
Ye, Xinyu ;
Zhang, Hong ;
Xu, Xiaogang ;
Li, Wanhua ;
Zhu, Demei ;
Wang, Minggui .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :2160-2162
[4]   Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan [J].
Matsuoka, M ;
Narita, M ;
Okazaki, N ;
Ohya, H ;
Yamazaki, T ;
Ouchi, K ;
Suzuki, I ;
Andoh, T ;
Kenri, T ;
Sasaki, Y ;
Horino, A ;
Shintani, M ;
Arakawa, Y ;
Sasaki, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4624-4630
[5]   Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation [J].
Morozumi, M ;
Hasegawa, K ;
Kobayashi, R ;
Inoue, N ;
Iwata, S ;
Kuroki, H ;
Kawamura, N ;
Nakayama, E ;
Tajima, T ;
Shimizu, K ;
Ubukata, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) :2302-2306
[6]   Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia [J].
Morozumi, Miyuki ;
Iwata, Satoshi ;
Hasegawa, Keiko ;
Chiba, Naoko ;
Takayanagi, Reiko ;
Matsubara, Keita ;
Nakayama, Eiichi ;
Sunakawa, Keisuke ;
Ubukata, Kimiko .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) :348-350
[7]   Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro [J].
Okazaki, N ;
Narita, M ;
Yamada, S ;
Izumikawa, K ;
Umetsu, M ;
Kenri, T ;
Sasaki, Y ;
Arakawa, Y ;
Sasaki, T .
MICROBIOLOGY AND IMMUNOLOGY, 2001, 45 (08) :617-620
[8]   Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori [J].
Oleastro, M ;
Ménard, A ;
Santos, A ;
Lamouliatte, H ;
Monteiro, L ;
Barthélémy, P ;
Mégraud, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :397-402
[9]   Detection of azithromycin resistance in Treponema pallidum by real-time PCR [J].
Pandori, Mark W. ;
Gordones, Charmie ;
Castro, Lina ;
Engelman, Joseph ;
Siedner, Mark ;
Lukehart, Sheila ;
Klausner, Jeffrey .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (09) :3425-3430
[10]   First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years [J].
Pereyre, S. ;
Charron, A. ;
Renaudin, H. ;
Bebear, C. ;
Bebear, C. M. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (11) :3534-3539